Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Hernán MA[au]:

Per-Protocol Analyses of Pragmatic Trials. Hernán MA et al. N Engl J Med. (2017)

Does water kill? A call for less casual causal inferences. Hernán MA et al. Ann Epidemiol. (2016)

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. Sterne JA et al. BMJ. (2016)

Search results

Items: 1 to 50 of 244

1.

Partial Identification of the Average Treatment Effect Using Instrumental Variables: Review of Methods for Binary Instruments, Treatments, and Outcomes.

Swanson SA, Hernán MA, Miller M, Robins JM, Richardson TS.

J Am Stat Assoc. 2018;113(522):933-947. doi: 10.1080/01621459.2018.1434530. Epub 2018 Jul 25.

PMID:
31537952
2.

On the Relation Between G-formula and Inverse Probability Weighting Estimators for Generalizing Trial Results.

Dahabreh IJ, Robertson SE, Hernán MA.

Epidemiology. 2019 Sep 10. doi: 10.1097/EDE.0000000000001097. [Epub ahead of print]

PMID:
31517670
3.

Interval-cohort designs and bias in the estimation of per-protocol effects: a simulation study.

Young JG, Vatsa R, Murray EJ, Hernán MA.

Trials. 2019 Sep 5;20(1):552. doi: 10.1186/s13063-019-3577-z.

4.

RoB 2: a revised tool for assessing risk of bias in randomised trials.

Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, Emberson JR, Hernán MA, Hopewell S, Hróbjartsson A, Junqueira DR, Jüni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT.

BMJ. 2019 Aug 28;366:l4898. doi: 10.1136/bmj.l4898. No abstract available.

5.

Extending inferences from a randomized trial to a target population.

Dahabreh IJ, Hernán MA.

Eur J Epidemiol. 2019 Aug;34(8):719-722. doi: 10.1007/s10654-019-00533-2. Epub 2019 Jun 19. No abstract available.

PMID:
31218483
6.

Effect estimates in randomized trials and observational studies: comparing apples with apples.

Lodi S, Phillips A, Lundgren J, Logan R, Sharma S, Cole SR, Babiker A, Law M, Chu H, Byrne D, Horban A, Sterne JAC, Porter K, Sabin C, Costagliola D, Abgrall S, Gill J, Touloumi G, Pacheco AG, van Sighem A, Reiss P, Bucher HC, Montoliu Giménez A, Jarrin I, Wittkop L, Meyer L, Perez-Hoyos S, Justice A, Neaton JD, Hernán MA; INSIGHT START Study Group and the HIV-CAUSAL Collaboration.

Am J Epidemiol. 2019 May 7. pii: kwz100. doi: 10.1093/aje/kwz100. [Epub ahead of print]

PMID:
31063192
7.

Emulating a trial of joint dynamic strategies: An application to monitoring and treatment of HIV-positive individuals.

Caniglia EC, Robins JM, Cain LE, Sabin C, Logan R, Abgrall S, Mugavero MJ, Hernández-Díaz S, Meyer L, Seng R, Drozd DR, Seage Iii GR, Bonnet F, Le Marec F, Moore RD, Reiss P, van Sighem A, Mathews WC, Jarrín I, Alejos B, Deeks SG, Muga R, Boswell SL, Ferrer E, Eron JJ, Gill J, Pacheco A, Grinsztejn B, Napravnik S, Jose S, Phillips A, Justice A, Tate J, Bucher HC, Egger M, Furrer H, Miro JM, Casabona J, Porter K, Touloumi G, Crane H, Costagliola D, Saag M, Hernán MA.

Stat Med. 2019 Jun 15;38(13):2428-2446. doi: 10.1002/sim.8120. Epub 2019 Mar 18.

PMID:
30883859
8.

Estimating the Effect of Preventive Services with Databases of Administrative Claims: Reasons to Be Concerned.

García-Albéniz X, Hsu J, Bretthauer M, Hernán MA.

Am J Epidemiol. 2019 Mar 14. pii: kwz049. doi: 10.1093/aje/kwz049. [Epub ahead of print] No abstract available.

PMID:
30869122
9.

The meaning of confounding adjustment in the presence of multiple versions of treatment: an application to organ transplantation.

Wanis KN, Madenci AL, Dokus MK, Orloff MS, Levstik MA, Hernandez-Alejandro R, Hernán MA.

Eur J Epidemiol. 2019 Mar;34(3):225-233. doi: 10.1007/s10654-019-00484-8. Epub 2019 Jan 23.

PMID:
30673924
10.

Guideline-Based Physical Activity and Survival Among US Men With Nonmetastatic Prostate Cancer.

Dickerman BA, Giovannucci E, Pernar CH, Mucci LA, Hernán MA.

Am J Epidemiol. 2019 Mar 1;188(3):579-586. doi: 10.1093/aje/kwy261.

PMID:
30496346
11.

Generalizing causal inferences from individuals in randomized trials to all trial-eligible individuals.

Dahabreh IJ, Robertson SE, Tchetgen EJ, Stuart EA, Hernán MA.

Biometrics. 2019 Jun;75(2):685-694. doi: 10.1111/biom.13009. Epub 2019 Jun 21.

PMID:
30488513
12.

The Effect of the Opioid Epidemic on Donation After Circulatory Death Transplantation Outcomes.

Wanis KN, Madenci AL, Dokus MK, Tomiyama K, Al-Judaibi BM, Hernán MA, Hernandez-Alejandro R.

Transplantation. 2019 May;103(5):973-979. doi: 10.1097/TP.0000000000002467.

PMID:
30273236
13.

Patients and investigators prefer measures of absolute risk in subgroups for pragmatic randomized trials.

Murray EJ, Caniglia EC, Swanson SA, Hernández-Díaz S, Hernán MA.

J Clin Epidemiol. 2018 Nov;103:10-21. doi: 10.1016/j.jclinepi.2018.06.009. Epub 2018 Jun 30.

PMID:
29966732
14.

Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.

Estruch R, Ros E, Salas-Salvadó J, Covas MI, Corella D, Arós F, Gómez-Gracia E, Ruiz-Gutiérrez V, Fiol M, Lapetra J, Lamuela-Raventos RM, Serra-Majem L, Pintó X, Basora J, Muñoz MA, Sorlí JV, Martínez JA, Fitó M, Gea A, Hernán MA, Martínez-González MA; PREDIMED Study Investigators.

N Engl J Med. 2018 Jun 21;378(25):e34. doi: 10.1056/NEJMoa1800389. Epub 2018 Jun 13.

15.

Association of Statin Use With Overall and Cancer Survival-Reply.

Emilsson L, García-Albéniz X, Hernan MA.

JAMA Oncol. 2018 Jul 1;4(7):1016-1017. doi: 10.1001/jamaoncol.2018.0736. No abstract available.

PMID:
29800046
16.

Causal null hypotheses of sustained treatment strategies: What can be tested with an instrumental variable?

Swanson SA, Labrecque J, Hernán MA.

Eur J Epidemiol. 2018 Aug;33(8):723-728. doi: 10.1007/s10654-018-0396-6. Epub 2018 May 2. Review.

17.

Long-Term Effectiveness of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality in Women and Men: A Randomized Trial.

Holme Ø, Løberg M, Kalager M, Bretthauer M, Hernán MA, Aas E, Eide TJ, Skovlund E, Lekven J, Schneede J, Tveit KM, Vatn M, Ursin G, Hoff G; NORCCAP Study Group†.

Ann Intern Med. 2018 Jun 5;168(11):775-782. doi: 10.7326/M17-1441. Epub 2018 Apr 24.

PMID:
29710125
18.

Assessment of recording bias in pregnancy studies using health care databases: An application to neurologic conditions.

MacDonald SC, Hernán MA, McElrath TF, Hernández-Díaz S.

Paediatr Perinat Epidemiol. 2018 May;32(3):281-286. doi: 10.1111/ppe.12459. Epub 2018 Mar 22.

19.

The C-Word: Scientific Euphemisms Do Not Improve Causal Inference From Observational Data.

Hernán MA.

Am J Public Health. 2018 May;108(5):616-619. doi: 10.2105/AJPH.2018.304337. Epub 2018 Mar 22.

20.

Cautions as Regulators Move to End Exclusive Reliance on Intention to Treat.

Hernán MA, Scharfstein D.

Ann Intern Med. 2018 Apr 3;168(7):515-516. doi: 10.7326/M17-3354. Epub 2018 Mar 20. No abstract available.

PMID:
29554689
21.

Improved adherence adjustment in the Coronary Drug Project.

Murray EJ, Hernán MA.

Trials. 2018 Mar 5;19(1):158. doi: 10.1186/s13063-018-2519-5.

22.

How to estimate the effect of treatment duration on survival outcomes using observational data.

Hernán MA.

BMJ. 2018 Feb 1;360:k182. doi: 10.1136/bmj.k182. No abstract available.

PMID:
29419381
23.

Electronic medical records can be used to emulate target trials of sustained treatment strategies.

Danaei G, García Rodríguez LA, Cantero OF, Logan RW, Hernán MA.

J Clin Epidemiol. 2018 Apr;96:12-22. doi: 10.1016/j.jclinepi.2017.11.021.

24.

Using Observational Data to Calibrate Simulation Models.

Murray EJ, Robins JM, Seage GR 3rd, Lodi S, Hyle EP, Reddy KP, Freedberg KA, Hernán MA.

Med Decis Making. 2018 Feb;38(2):212-224. doi: 10.1177/0272989X17738753. Epub 2017 Nov 15.

25.

Effect of immediate initiation of antiretroviral treatment on the risk of acquired HIV drug resistance.

Lodi S, Günthard HF, Dunn D, Garcia F, Logan R, Jose S, Bucher HC, Scherrer AU, Schneider MP, Egger M, Glass TR, Reiss P, van Sighem A, Boender TS, Phillips AN, Porter K, Hawkins D, Moreno S, Monge S, Paraskevis D, Simeon M, Vourli G, Sabin C, Hernán MA; HIV-CAUSAL Collaboration.

AIDS. 2018 Jan 28;32(3):327-335. doi: 10.1097/QAD.0000000000001692.

26.

Emulating a target trial of antiretroviral therapy regimens started before conception and risk of adverse birth outcomes.

Caniglia EC, Zash R, Jacobson DL, Diseko M, Mayondi G, Lockman S, Chen JY, Mmalane M, Makhema J, Hernán MA, Shapiro RL.

AIDS. 2018 Jan 2;32(1):113-120. doi: 10.1097/QAD.0000000000001673.

27.

Correspondence Between Results and Aims of Funding Support in EPIDEMIOLOGY Articles.

Lash TL, Kaufman JS, Hernán MA.

Epidemiology. 2018 Jan;29(1):1-4. doi: 10.1097/EDE.0000000000000767. No abstract available.

PMID:
29023240
28.

Commonly Prescribed Antiretroviral Therapy Regimens and Incidence of AIDS-Defining Neurological Conditions.

Caniglia EC, Phillips A, Porter K, Sabin CA, Winston A, Logan R, Gill J, Vandenhende MA, Barger D, Lodi S, Moreno S, Arribas JR, Pacheco A, Cardoso SW, Chrysos G, Gogos C, Abgrall S, Costagliola D, Meyer L, Seng R, van Sighem A, Reiss P, Muga R, Hoyos SP, Braun D, Hauser C, Barrufet P, Leyes M, Tate J, Justice A, Hernán MA.

J Acquir Immune Defic Syndr. 2018 Jan 1;77(1):102-109. doi: 10.1097/QAI.0000000000001562.

29.

Per-Protocol Analyses of Pragmatic Trials.

Hernán MA, Robins JM.

N Engl J Med. 2017 Oct 5;377(14):1391-1398. doi: 10.1056/NEJMsm1605385. No abstract available.

PMID:
28976864
30.

A Comparison of Agent-Based Models and the Parametric G-Formula for Causal Inference.

Murray EJ, Robins JM, Seage GR, Freedberg KA, Hernán MA.

Am J Epidemiol. 2017 Jul 15;186(2):131-142. doi: 10.1093/aje/kwx091.

31.

Examining Bias in Studies of Statin Treatment and Survival in Patients With Cancer.

Emilsson L, García-Albéniz X, Logan RW, Caniglia EC, Kalager M, Hernán MA.

JAMA Oncol. 2018 Jan 1;4(1):63-70. doi: 10.1001/jamaoncol.2017.2752. Erratum in: JAMA Oncol. 2018 Jan 1;4(1):133.

32.

The value of explicitly emulating a target trial when using real world evidence: an application to colorectal cancer screening.

García-Albéniz X, Hsu J, Hernán MA.

Eur J Epidemiol. 2017 Jun;32(6):495-500. doi: 10.1007/s10654-017-0287-2. Epub 2017 Jul 26.

33.

Effect of Immediate Initiation of Antiretroviral Treatment in HIV-Positive Individuals Aged 50 Years or Older.

Lodi S, Costagliola D, Sabin C, Del Amo J, Logan R, Abgrall S, Reiss P, van Sighem A, Jose S, Blanco JR, Hernando V, Bucher HC, Kovari H, Segura F, Ambrosioni J, Gogos CA, Pantazis N, Dabis F, Vandenhende MA, Meyer L, Seng R, Gill MJ, Krentz H, Phillips AN, Porter K, Grinsztejn B, Pacheco AG, Muga R, Tate J, Justice A, Hernán MA.

J Acquir Immune Defic Syndr. 2017 Nov 1;76(3):311-318. doi: 10.1097/QAI.0000000000001498.

34.

Nature as a Trialist?: Deconstructing the Analogy Between Mendelian Randomization and Randomized Trials.

Swanson SA, Tiemeier H, Ikram MA, Hernán MA.

Epidemiology. 2017 Sep;28(5):653-659. doi: 10.1097/EDE.0000000000000699.

35.

Comparing the Effectiveness of Dynamic Treatment Strategies Using Electronic Health Records: An Application of the Parametric g-Formula to Anemia Management Strategies.

Zhang Y, Young JG, Thamer M, Hernán MA.

Health Serv Res. 2018 Jun;53(3):1900-1918. doi: 10.1111/1475-6773.12718. Epub 2017 May 30.

36.

Invited Commentary: Selection Bias Without Colliders.

Hernán MA.

Am J Epidemiol. 2017 Jun 1;185(11):1048-1050. doi: 10.1093/aje/kwx077.

37.

Screening Colonoscopy to Prevent Colorectal Cancer Among Medicare Beneficiaries Aged 70 to 79 Years.

García-Albéniz X, Hsu J, Bretthauer M, Hernán MA.

Ann Intern Med. 2017 May 16;166(10):758-759. doi: 10.7326/L17-0138. No abstract available.

PMID:
28505646
38.

Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study.

Caniglia EC, Cain LE, Sabin CA, Robins JM, Logan R, Abgrall S, Mugavero MJ, Hernández-Díaz S, Meyer L, Seng R, Drozd DR, Seage GR 3rd, Bonnet F, Dabis F, Moore RD, Reiss P, van Sighem A, Mathews WC, Del Amo J, Moreno S, Deeks SG, Muga R, Boswell SL, Ferrer E, Eron JJ, Napravnik S, Jose S, Phillips A, Justice AC, Tate JP, Gill J, Pacheco A, Veloso VG, Bucher HC, Egger M, Furrer H, Porter K, Touloumi G, Crane H, Miro JM, Sterne JA, Costagliola D, Saag M, Hernán MA; HIV-CAUSAL Collaboration; Centers for AIDS Research Network of Integrated Clinical Systems.

Lancet HIV. 2017 Jun;4(6):e251-e259. doi: 10.1016/S2352-3018(17)30043-7. Epub 2017 Apr 11.

39.

The challenging interpretation of instrumental variable estimates under monotonicity.

Swanson SA, Hernán MA.

Int J Epidemiol. 2018 Aug 1;47(4):1289-1297. doi: 10.1093/ije/dyx038.

40.

The Authors Respond.

Mansournia MA, Hernán MA.

Epidemiology. 2017 Jul;28(4):e41. doi: 10.1097/EDE.0000000000000662. No abstract available.

41.

Comparative Effectiveness Research Using Observational Data: Active Comparators to Emulate Target Trials with Inactive Comparators.

Huitfeldt A, Hernan MA, Kalager M, Robins JM.

EGEMS (Wash DC). 2016 Oct 14;4(1):1234. eCollection 2016.

42.

Does water kill? A call for less casual causal inferences.

Hernán MA.

Ann Epidemiol. 2016 Oct;26(10):674-680. doi: 10.1016/j.annepidem.2016.08.016. Epub 2016 Aug 31. Review.

43.

The per-protocol effect of immediate versus deferred antiretroviral therapy initiation.

Lodi S, Sharma S, Lundgren JD, Phillips AN, Cole SR, Logan R, Agan BK, Babiker A, Klinker H, Chu H, Law M, Neaton JD, Hernán MA; INSIGHT Strategic Timing of AntiRetroviral Treatment (START) study group.

AIDS. 2016 Nov 13;30(17):2659-2663.

44.

Biases in Randomized Trials: A Conversation Between Trialists and Epidemiologists.

Mansournia MA, Higgins JP, Sterne JA, Hernán MA.

Epidemiology. 2017 Jan;28(1):54-59. Erratum in: Epidemiology. 2018 Sep;29(5):e49.

45.

Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: A prospective study of HIV-positive individuals.

Cain LE, Caniglia EC, Phillips A, Olson A, Muga R, Pérez-Hoyos S, Abgrall S, Costagliola D, Rubio R, Jarrín I, Bucher H, Fehr J, van Sighem A, Reiss P, Dabis F, Vandenhende MA, Logan R, Robins J, Sterne JA, Justice A, Tate J, Touloumi G, Paparizos V, Esteve A, Casabona J, Seng R, Meyer L, Jose S, Sabin C, Hernán MA; HIV-CAUSAL Collaboration.

Medicine (Baltimore). 2016 Oct;95(41):e5133.

46.

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.

Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, Carpenter JR, Chan AW, Churchill R, Deeks JJ, Hróbjartsson A, Kirkham J, Jüni P, Loke YK, Pigott TD, Ramsay CR, Regidor D, Rothstein HR, Sandhu L, Santaguida PL, Schünemann HJ, Shea B, Shrier I, Tugwell P, Turner L, Valentine JC, Waddington H, Waters E, Wells GA, Whiting PF, Higgins JP.

BMJ. 2016 Oct 12;355:i4919. doi: 10.1136/bmj.i4919. No abstract available.

47.

Smoking cessation and long-term weight gain in the Framingham Heart Study: an application of the parametric g-formula for a continuous outcome.

Jain P, Danaei G, Robins JM, Manson JE, Hernán MA.

Eur J Epidemiol. 2016 Dec;31(12):1223-1229. doi: 10.1007/s10654-016-0200-4. Epub 2016 Oct 4.

48.

Effectiveness of Screening Colonoscopy to Prevent Colorectal Cancer Among Medicare Beneficiaries Aged 70 to 79 Years: A Prospective Observational Study.

García-Albéniz X, Hsu J, Bretthauer M, Hernán MA.

Ann Intern Med. 2017 Jan 3;166(1):18-26. doi: 10.7326/M16-0758. Epub 2016 Sep 27.

49.

Re: Causality and causal inference in epidemiology: the need for a pluralistic approach.

VanderWeele TJ, Hernán MA, Tchetgen Tchetgen EJ, Robins JM.

Int J Epidemiol. 2016 Dec 1;45(6):2199-2200. doi: 10.1093/ije/dyw162. No abstract available.

PMID:
27524811
50.

Colonoscopy and Risk of Infective Endocarditis in the Elderly.

García-Albéniz X, Hsu J, Lipsitch M, Bretthauer M, Logan RW, Hernández-Díaz S, Hernán MA.

J Am Coll Cardiol. 2016 Aug 2;68(5):570-571. doi: 10.1016/j.jacc.2016.05.041. No abstract available.

Supplemental Content

Loading ...
Support Center